Lactams
Chemscene ChemScene | Thalidomide 5-fluoride | 5G | CS-0127616 | 0.98 | 835616-61-0| MFCD30188075 | 276.22
ChemScene | Thalidomide 5-fluoride | 5G | CS-0127616 | 0.98 | 835616-61-0| MFCD30188075 | 276.22
![Medchemexpress LLC 6H-Thieno[3,2-f]triazolo[4,3-a]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, cyclopropyl ester, (6S)- | 3077900-08-1 | 98.3% | 440.95 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000387076-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 6H-Thieno[3,2-f]triazolo[4,3-a]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, cyclopropyl ester, (6S)- | 3077900-08-1 | 98.3% | 440.95 | 5 MG
DDL-357 is a potent enhancer of secreted clusterin. It has been shown to reduce phospho-tau levels in the brain and improve memory in the murine 3xTg-AD model. It is intended for research use only and not for sale to patients.
- Purity: 98.31%
- Appearance: Solid
- Color: White to off-white
- Shipping: Room temperature in continental US; may vary elsewhere.
- Storage (powder): -20°C for 3 years, 4°C for 2 years.
- Storage (in solvent): -80°C for 6 months, -20°C for 1 month.
- Solubility (in vitro): 100 mg/mL in DMSO (226.78 mM; requires ultrasonic, hygroscopic DMSO affects solubility).
- Solubility (in vivo - protocol 1): ≥ 5 mg/mL (11.34 mM) in a mixture of 10% DMSO, 40% PEG300, 5% Tween-80, and 45% Saline, yielding a clear solution.
Medchemexpress LLC VH 101 phenol-alkylC4-amine dihydrochloride | 2564467-03-2 | 676.67 | 1MG
VH 101 phenol-alkylC4-amine dihydrochloride is a von-Hippel-Lindau protein ligand (VHL), which incorporates an E3 ligase ligand and an alkylC4 linker. It can be utilized for PROTAC research.
- Von-Hippel-Lindau protein ligand (VHL)
- Incorporates an E3 ligase ligand
- Incorporates an alkylC4 linker
- Suitable for PROTAC research
- Extracted from patent WO2022051326A1
Medchemexpress LLC Thalidomide-NH-C6-NH2 TFA | 2093386-51-5 | 99.8% | 1 G
Thalidomide-NH-C6-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate, incorporating a Thalidomide-based cereblon ligand and a linker used in PROTAC technology. This compound is characterized by its high purity of 99.8%.
- Synthesized E3 ligase ligand-linker conjugate
- Incorporates Thalidomide-based cereblon ligand
- Features a linker used in PROTAC technology
- Designed for use in PROTACs that exploit the intracellular ubiquitin-proteasome system
Medchemexpress LLC Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride | 2983037-00-7 | >98.0% | 586.03 | 25 MG
Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate. It integrates a thalidomide-based cereblon ligand with a linker, making it suitable for applications in PROTAC technology. This compound is intended for research purposes only and is not for sale to patients.
- Synthesized E3 ligase ligand-linker conjugate
- Incorporates thalidomide-based cereblon ligand
- Utilizes a linker for PROTAC technology applications
- Suitable for research use
TARGETMOL CHEMICALS INC S-THALIDOMIDE 5MG
Also available in 10mg 25mg 50mg 100mg 500mg and bulk. Please contact Fisher for quotes. (S)-Thalidomide ((S)-(-)-Thalidomide) is the S-isomer of Thalidomide with immunomodulatory anti-inflammatory anticancer anti-angiogenic and pro-apoptotic activities and is used in the study of leprosy erythema nodosum and myeloma. purity: 99%
Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 99.7% | 337.13 g·mol⁻¹ | C13H9BrN2O4 | 10 MG
Thalidomide-4-Br is a brominated derivative of thalidomide that acts as a small-molecule bromodomain probe. It is provided as a high-purity solid for in vitro and preclinical research in inflammation, oncology, and neurology.
- Bromodomain-containing small molecule probe.
- Suitable for inflammation, tumor, and neurology research.
- High purity: 99.7%.
- Molecular formula C13H9BrN2O4; molecular weight 337.13 g·mol⁻¹.
- Available in multiple pack sizes including 10 mg.
- Powder storage: -20°C (3 years) or 4°C (2 years).